LEADER 03837nam  22006855  450 
001 9910298296003321
005 20200703060053.0
010   $a3-319-13611-9
024 7 $a10.1007/978-3-319-13611-0
035   $a(CKB)3710000000414155
035   $a(EBL)2094202
035   $a(SSID)ssj0001500665
035   $a(PQKBManifestationID)11967967
035   $a(PQKBTitleCode)TC0001500665
035   $a(PQKBWorkID)11522855
035   $a(PQKB)10155694
035   $a(DE-He213)978-3-319-13611-0
035   $a(MiAaPQ)EBC2094202
035   $a(PPN)186025432
035   $a(EXLCZ)993710000000414155
100   $a20150512d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aNitric Oxide and Cancer: Pathogenesis and Therapy /$fedited by Benjamin Bonavida
205   $a1st ed. 2015.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015.
215   $a1 online resource (319 p.)
300   $aDescription based upon print version of record.
311   $a3-319-13610-0 
327   $aInflammation-associated Carcinogenesis Involved Interaction Between with iNOS/NO and WNT/beta-catenin -- NO and Genomic Stability -- Targeting Hyponitroxia in Cancer Therapy -- Mechanism of NO-dependent Regulation of Invasion and Metastasis -- NO Role in Protumorigenesis and Hypoxia -- Impacts of S-nitrosylation in Cancer -- S-nitrosylation of Cancer Cells -- Role of S-nitrosylation in Cancer Metastasis -- NO Immunity and Cancer -- Regulation of Anti-tumor Responses by NO -- NO Immune Modulation and Tumor Growth -- Role of NO in Chemo-immune Resistance -- Emerging Role of NO-mediated Therapeutics -- PDT and NO -- Regulation of Cell Death by NO -- Discovery and Development of RRx-001 -- Nitric Oxide Coagulation and Cancer -- Neutrosphyngomyelinase 2.
330   $aNitric Oxide and Cancer: Pathogenesis and Therapy provides the latest research and applications of nitric oxide (NO) in cancer written by experts in the field. The volume reviews significant advances in the biochemical and molecular biology of NO-mediated effects in cancer. Additionally, it explores NO and its relationship to cancer, delineating its roles in the pathogenesis, prognosis, gene and protein modifications, regulation of resistance to cytotoxic drugs and immunotherapies, and potential therapeutic applications. Nitric Oxide and Cancer addresses the burgeoning interest in a rapidly advancing field, and serves as both a valuable resource for scientists, clinicians, students, and health professionals and a reference for teaching and educational purposes.
606   $aCancer$xResearch
606   $aMolecular biology
606   $aPharmacology
606   $aDrug resistance
606   $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001
606   $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aDrug Resistance$3https://scigraph.springernature.com/ontologies/product-market-codes/B16020
615  0$aCancer$xResearch.
615  0$aMolecular biology.
615  0$aPharmacology.
615  0$aDrug resistance.
615 14$aCancer Research.
615 24$aMolecular Medicine.
615 24$aPharmacology/Toxicology.
615 24$aDrug Resistance.
676   $a610
676   $a611.01816
676   $a614.5999
676   $a615
676   $a616.9041
702   $aBonavida$b Benjamin$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298296003321
996   $aNitric Oxide and Cancer: Pathogenesis and Therapy$92499297
997   $aUNINA